Skip to main content
. 2020 Feb 24;43(5):1375–1386. doi: 10.3892/or.2020.7515

Table I.

Demographic and clinicopathological information of the 58 BC patients.

METTL14 expression

Characteristics No. of patients Low n (%) High n (%) P-value
Age (years) 0.5992
  <60 28 15 (53.5) 13 (46.5)
  ≥60 30 14 (46.7) 16 (53.3)
Typing 0.9389
  Luminal A   4 2 (50) 2 (50)
  Luminal B 33 16 (39.4) 17 (60.6)
  HER-2+   9 5 (55.6) 4 (44.4)
  Basal-like 12 5 (41.7) 7 (58.3)
Microvascular invasion 0.4297
  Yes 27 12 (44.4) 15 (55.6)
  No 31 17 (54.8) 14 (45.2)
Nerve invasion 0.6489
  Yes 15 7 (46.7) 8 (53.3)
  No 43 23 (53.5) 20 (46.5)
TNM 0.0483a
  T1+T2 54 30 (55.6) 24 (44.4)
  T3   4   0 4 (100)
Pathological stage 0.0827
  I+II 47 22 (46.8) 25 (53.2)
  III 11 2 (18.2) 9 (81.8)
WHO 0.0768
  I+II 27 12 (44.4) 15 (55.6)
  III 31 7 (22.6) 24 (77.4)
Metastasis 0.2389
  pN0+pN1 47 22 (46.8) 25 (53.2)
  pN2+pN3 11 3 (27.3) 8 (72.7)
a

P<0.05, represents a significant difference. BC, breast cancer; METTL14, methyltransferase like 14.